Why Did Ted Lieu Question Trump Over an Experimental Dr*g?

A report revealed that an unidentified 79-year-old man received early access to Eli Lilly’s experimental dr*g retatrutide through the FDA’s compassionate-use program. Rep. Ted Lieu is now asking whether President Donald Trump was the recipient. The White House has denied that Trump received the dr*g.